Evaluating the Safety and Efficacy of Anti-Influenza Intravenous Hyperimmune Immunoglobulin (IVIG) in Adults Hospitalized With Influenza

NCT02287467 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

329

Enrollment

NIH

Sponsor class

Conditions

Influenza A
Influenza B

Interventions

BIOLOGICAL: Intravenous hyperimmune immunoglobulin (IVIG)
BIOLOGICAL: Placebo for IVIG

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborators

[object Object]
[object Object]